Pacira BioSciences PCRX
NASDAQ PCRX
$36.47 +0.01 (+0.03%)
As of: Nov 12, 2026 · 1:09 PM EST

Pacira BioSciences (PCRX) Return on Invested Capital [ROIC] (2013 - 2026)

Updated

Pacira BioSciences (PCRX) recorded Return on Invested Capital [ROIC] of 1.60% in Q2 2026, up 11.26 percentage points from -9.66% a year earlier and up 0.70 percentage points from the prior quarter.

Analysis

Pacira BioSciences (PCRX) Return on Invested Capital [ROIC] (2013 - 2026) Analysis & Trends

For FY2025, Pacira BioSciences reported Return on Invested Capital [ROIC] of 0.66%, up 6.88 percentage points from FY2024.

  • Annual Return on Invested Capital [ROIC] has a five-year change of -7.59 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Invested Capital [ROIC] came in at -6.22% in FY2024 (-12.03 pp), 5.81% in FY2023 (+0.96 pp), 4.85% in FY2022 (-1.28 pp) and 6.12% in FY2021 (-2.12 pp).
  • Quarterly Return on Invested Capital [ROIC] has ranged from -9.66% in Q2 2025 to 9.96% in Q3 2021 over the past five years.
  • On a year-over-year basis, Return on Invested Capital [ROIC] has increased for four consecutive quarters, with an average year-over-year change of -2.15 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Invested Capital [ROIC] in the last five years was a gain of 11.26 percentage points in Q2 2026, against a drop of 15.49 percentage points in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at 0.90% (Q1 2026), 0.74% (Q4 2025) and 1.97% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 30.89%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.57%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.28%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.52%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 23.11%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 15.60%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.11%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 12.34%
10 Pacira BioSciences 1.46 Bn 468.61 Mn 139.42 Mn 3.51%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.51%
Jun 30, 2026 1.60%
Mar 31, 2026 0.90%
Dec 31, 2025 0.74%
Sep 30, 2025 1.97%
Jun 30, 2025 -9.66%
Mar 31, 2025 -6.86%
Dec 31, 2024 -6.06%
Sep 30, 2024 -6.34%
Jun 30, 2024 5.83%
Mar 31, 2024 7.17%
Dec 31, 2023 6.11%
Sep 30, 2023 3.27%
Jun 30, 2023 5.07%
Mar 31, 2023 2.04%
Dec 31, 2022 5.52%
Sep 30, 2022 5.53%
Jun 30, 2022 5.97%
Mar 31, 2022 4.96%
Dec 31, 2021 5.78%
API Access

Pacira BioSciences Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=PCRX&period=max&api_key=YOUR_API_KEY